Diarrhoea (grade 2+) · people with Rectal Cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
QoL · people with Rectal Cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Hypertensive disorders of pregnancy: severe hypertension or pre‐eclampsia · pregnant women with GDM
It is very uncertain whether summary of findings: Low‐moderate GI diet changes hypertensive disorders of pregnancy: severe hypertension or… compared with moderate‐high GI diet (maternal outcomes) (very low certainty).
1 finding from 1 review
Perinatal mortality · pregnant women with GDM
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health status and well‐being – neonatal morbidity and mortality combined · pregnant women with GDM
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Neonatal hypoglycaemia · pregnant women with GDM
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Neurosensory disability · pregnant women with GDM
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Childhood/adulthood adiposity · pregnant women with GDM
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Childhood/adulthood type 2 diabetes mellitus · pregnant women with GDM
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Eclampsia · pregnant women with GDM
It is very uncertain whether summary of findings: Low‐moderate GI diet changes hypertensive disorders of pregnancy: eclampsia compared with moderate‐high GI diet (maternal outcomes) (very low certainty).
1 finding from 1 review
Caesarean section · pregnant women with GDM
Summary of findings: Low‐moderate GI diet showed no clear difference in caesarean section compared with moderate‐high GI diet (maternal outcomes) (low certainty).
1 finding from 1 review
Induction of labour · pregnant women with GDM
Summary of findings: Low‐moderate GI diet showed no clear difference in induction of labour compared with moderate‐high GI diet (maternal outcomes) (low certainty).
1 finding from 1 review
Perineal trauma · pregnant women with GDM
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Type 2 diabetes mellitus · pregnant women with GDM
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Postnatal depression · pregnant women with GDM
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Postnatal weight retention or return to pre‐pregnancy weight · pregnant women with GDM
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Large‐for‐gestational age · pregnant women with GDM
Summary of findings: Low‐moderate GI diet showed no clear difference in large‐for‐gestational age compared with moderate‐high GI diet (neonatal/child/adulthood outcomes) (low certainty).
1 finding from 1 review
Incidence of hepatic veno‐occlusive disease ( · Patients undergoing stem cell transplant with malignant and non‐malignant diseases
Summary of findings: Ursodeoxycholic acid may leads to lower incidence of hepatic veno‐occlusive disease ( compared with placebo or no treatment (low certainty).
1 finding from 1 review
Overall survival ( · Patients undergoing stem cell transplant with malignant and non‐malignant diseases
Summary of findings: Ursodeoxycholic acid showed no clear difference in overall survival ( compared with placebo or no treatment (low certainty).
1 finding from 1 review
All‐cause mortality at 100 days post‐transplant · Patients undergoing stem cell transplant with malignant and non‐malignant diseases
Summary of findings: Ursodeoxycholic acid may leads to lower all‐cause mortality at 100 days post‐transplant ( compared with placebo or no treatment (low certainty).
1 finding from 1 review